T. Rowe Price Investment Management Portfolio holdings
T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.
Top Buys
| 1 |
McKesson
MCK
|
$1.1B |
| 2 |
Advanced Micro Devices
AMD
|
$673M |
| 3 |
Service Corp International
SCI
|
$664M |
| 4 |
NVIDIA
NVDA
|
$638M |
| 5 |
NXP Semiconductors
NXPI
|
$601M |
Top Sells
| 1 |
Waste Connections
WCN
|
$1.12B |
| 2 |
Exelon
EXC
|
$862M |
| 3 |
Veralto
VLTO
|
$772M |
| 4 |
Intercontinental Exchange
ICE
|
$730M |
| 5 |
Intuit
INTU
|
$708M |
Sector Composition
| 1 | Technology | 25.1% |
| 2 | Healthcare | 21.6% |
| 3 | Consumer Discretionary | 12.25% |
| 4 | Industrials | 10.78% |
| 5 | Financials | 10.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
626
BridgeBio Pharma
BBIO
$9.91B
| – | – |
-276,369
| Closed | -$7M |
|
627
BRC Inc
BRCC
$179M
| – | – |
-1,908,354
| Closed | -$11.7M |
|
628
Certara
CERT
$1.72B
| – | – |
-3,354,430
| Closed | -$46.5M |
|
629
CG Oncology
CGON
$2.38B
| – | – |
-66,596
| Closed | -$2.1M |
|
630
Clearwater Paper
CLW
$359M
| – | – |
-341,307
| Closed | -$16.5M |
|
631
Charles River Laboratories
CRL
$8.12B
| – | – |
-112,725
| Closed | -$23.3M |
|
632
Coterra Energy
CTRA
$18.5B
| – | – |
-11,745,718
| Closed | -$313M |
|
633
Frontier Communications
FYBR
$9.31B
| – | – |
-4,299,507
| Closed | -$113M |
|
634
Grifois
GRFS
$6.88B
| – | – |
-1,303,596
| Closed | -$8.21M |
|
635
HilleVax
HLVX
$105M
| – | – |
-3,481,222
| Closed | -$50.3M |
|
636
HubSpot
HUBS
$25.6B
| – | – |
-27,695
| Closed | -$16.3M |
|
637
Hydrofarm Holdings
HYFM
$14.7M
| – | – |
-79,676
| Closed | -$550K |
|
638
International Seaways
INSW
$2.3B
| – | – |
-37,080
| Closed | -$2.19M |
|
639
Johnson & Johnson
JNJ
$429B
| – | – |
-2,384
| Closed | -$349K |
|
640
Knowles
KN
$1.88B
| – | – |
-743,918
| Closed | -$12.8M |
|
641
Leslie's
LESL
$65.3M
| – | – |
-5,110,764
| Closed | -$21.4M |
|
642
Metropolitan Bank Holding Corp
MCB
$844M
| – | – |
-311,894
| Closed | -$13.1M |
|
643
Moody's
MCO
$90B
| – | – |
-3,530
| Closed | -$1.49M |
|
644
Madrigal Pharmaceuticals
MDGL
$9.72B
| – | – |
-25,644
| Closed | -$7.19M |
|
645
Noble Corp
NE
$4.58B
| – | – |
-1,473,961
| Closed | -$65.8M |
|
646
Napco Security Technologies
NSSC
$1.43B
| – | – |
-1,852,061
| Closed | -$96.2M |
|
|
NVEE
647
DELISTED
NV5 Global
NVEE
| – | – |
-1,662,780
| Closed | -$38.6M |
|
648
PotlatchDeltic
PCH
$3.34B
| – | – |
-472,190
| Closed | -$18.6M |
|
649
Public Service Enterprise Group
PEG
$40.8B
| – | – |
-4,085
| Closed | -$302K |
|
650
Prologis
PLD
$106B
| – | – |
-1,555
| Closed | -$175K |
|